FacebookTwitterGoogle+RedditEmail

Patient Front Groups Loot Medicare Dollars for Big Pharma

by MARTHA ROSENBERG

The Obama administration is finally addressing the expensive, dangerous and usually unnecessary psychiatric drugs that are footed by taxpayers in federal entitlement programs. It has proposed that insurers may limit Medicare coverage of certain classes of drugs that include Wellbutrin, Paxil and Prozac for depression and Abilify and Seroquel for schizophrenia.

How expensive are these drugs? 100 middle dose pills of the widely marketed Abilify cost as much as $1,644. 100 pills of Geodon are $958, Invega, $1,789, Risperdal, $953, Seroquel, $2,000 and Zyprexa, $1,680, if the brand name drugs are used, which drug company  lobbyists hope. Thanks to their lobbying, insurers have to pay “all or substantially all” of such depression and schizophrenia drug costs because the drugs enjoy “protected status” in the Medicare program. Such protected pills account for as much as 33 percent of total outpatient drug spending under Part D of Medicare, says the New York Times.

Not surprisingly, Big Pharma and its patient front groups are livid that the heisting of US taxpayers dollars could be curtailed. Abilify alone has earned over $4 billion a year! “The proposal undermines a key protection for some of the sickest, most vulnerable Medicare beneficiaries,” said Andrew Sperling, a lobbyist at the National Alliance on Mental Illness (NAMI) which is fighting the Obama proposal.

As much as 75 percent of NAMI’s donations come from drug companies says the New York Times and it has been investigated by Congress. Portraying itself as “patients,” NAMI also successfully fights states’ efforts to limit use of the most pricey Medicaid psychiatric drugs, in parallel lobbying. “Some of these medicines routinely top the list of the most expensive drugs that states buy for their poorest patients,” says the Times. NAMI is “hugely influential in many state capitols,” it adds.

The heart of Big Pharma and NAMI lobbying is making sure expensive drugs are on Medicare and Medicaid formularies and that doctors prescribe them first–before and instead of lower priced drugs. The expensive-drugs-first marketing is couched as “patient choice” or another “treatment option” by Pharma lobbyists as if there’s no difference between a $45 prescription and $450 prescription. Antipsychotic drugs work in different ways in the body explains Sperling and “You get much better outcomes when a doctor can work with patients to figure out which medications will work best for them.” Ka-ching.

The problem is newer, more expensive drugs are not necessarily better than older, less expensive drugs and they are often more dangerous. One chilling example is an estimated 15,000 elderly people die in nursing homes a year from inappropriately given antipsychotic medications, according to FDA drug reviewer David Graham, MD.  Pharma is aware of the profiteering and “laughing all the way to the bank,” Graham speculated.

Antipsychotics like Seroquel carry warnings that they cause death in elderly people who have dementia but are nevertheless in wide use in many geriatric, federally-supported facilities. So much for NAMI’s concern for “the sickest, most vulnerable Medicare beneficiaries.”

NAMI is not the only group to play on the public’s heart strings to keep drug revenues flowing. Pharma’s aggressive opioid lobby says patients with legitimate pain will suffer if drugs like Oxycontin, killing 17,000 Americans a year, are regulated. Similarly, if Abilify and Seroquel are regulated within Medicare, someone will suffer–Big Pharma.

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

 

 

 

 

 

More articles by:

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

January 23, 2018
Carl Boggs
Doomsday Panic in Hawaii
Mark Ashwill
If I Were US Ambassador to Vietnam…
Jack Rasmus
US Government Shutdown: Democrats Blink…Again
Nick Pemberton
The Inherent Whiteness of “Our Revolution”
Leeann Hall
Trump’s Gift for the Unemployed: Kicking Them Off Health Care
Dean Baker
Lessons in Economics For the NYT’s Bret Stephens: Apple and Donald Trump’s Big Tax Cut
Mitchell Zimmerman
Law, Order and the Dreamers
Ken Hannaford-Ricardi
The Kids the World Forgot
Dave Lindorff
South Korea Slips Off the US Leash
Ali Mohsin
Extrajudicial Murder of Pashtun Exposes State Brutality in Pakistan
Jessicah Pierre
Oprah is No Savior
John Carroll Md
Keeping Haiti in Perspective
Amir Khafagy
Marching Into the Arms of the Democrats
January 22, 2018
Patrick Cockburn
It’s Time to Call Economic Sanctions What They Are: War Crimes
Jim Kavanagh
Behind the Money Curtain: A Left Take on Taxes, Spending and Modern Monetary Theory
Sheldon Richman
Trump Versus the World
Mark Schuller
One Year On, Reflecting and Refining Tactics to Take Our Country Back
Winslow Wheeler
Just What Earmark “Moratorium” are They Talking About?
W. T. Whitney
José Martí, Soul of the Cuban Revolution
Uri Avnery
May Your Home Be Destroyed          
Wim Laven
Year One Report Card: Donald Trump Failing
Jill Richardson
There Are No Shithole Countries
Bob Fitrakis - Harvey Wasserman
Are the Supremes About to Give Trump a Second Term?
Laura Finley
After #MeToo and #TimesUp
Howard Lisnoff
Impressions From the Women’s March
Andy Thayer
HuffPost: “We Really LOVED Your Contributions, Now FUCK OFF!”
Weekend Edition
January 19, 2018
Friday - Sunday
Paul Street
Dr. King’s Long Assassination
David Roediger
A House is Not a Hole: (Not) Caring about What Trump Says
George Burchett
How the CIA Tried to Bribe Wilfred Burchett
Mike Whitney
Trump’s Plan B for Syria: Occupation and Intimidation
Michael Hudson – Charles Goodhart
Could/Should Jubilee Debt Cancellations be Reintroduced Today?
Marshall Auerback – Franklin C. Spinney
Boss Tweet’s Generals Already Run the Show
Andrew Levine
Remember, Democrats are Awful Too
James Bovard
Why Ruby Ridge Still Matters
Wilfred Burchett
The Bug Offensive
Brian Cloughley
Now Trump Menaces Pakistan
Ron Jacobs
Whiteness and Working Folks
Jeffrey St. Clair
The Keeper of Crazy Beats: Charlie Haden and Music as a Force of Liberation
Robert Fantina
Palestine and Israeli Recognition
Jan Oberg
The New US Syria “Strategy”, a Recipe For Continued Disaster
ADRIAN KUZMINSKI
The Return of the Repressed
Mel Gurtov
Dubious Partnership: The US and Saudi Arabia
Robert Fisk
The Next Kurdish War Looms on the Horizon
Lawrence Davidson
Contextualizing Sexual Harassment
Jeff Berg
Approaching Day Zero
FacebookTwitterGoogle+RedditEmail